IMMUNIC, INC. — Director's Dealing 2020

Oct 22, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2020-10-22

Reporting Person: Nash Duane (Director, Executive Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-22	Stock Option	$17.00	A	120000	Acquired	2030-10-22	Common Stock (120000)	Direct

Footnotes

F1: The shares underlying the option vest in six monthly installments beginning on November 15, 2020.